Cargando…

Renal Kallikrein Activation and Renoprotection after Dual Blockade of Renin-Angiotensin System in Diet-Induced Diabetic Nephropathy

Purpose. The objective of this study is to investigate the effect of dual blockage of renin-angiotensin system (RAS) on renal kallikrein expression and inflammatory response in diabetic nephropathy (DN). Methods. Rats were randomly divided into 5 groups with 10 rats in each group: normal control; DN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Xia, Zhang, Xiao-xi, Liu, Xin-yu, Li, Rong, Wang, Min, Wu, Wei-jie, Sui, Yi, Zhao, Hai-lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397032/ https://www.ncbi.nlm.nih.gov/pubmed/25918729 http://dx.doi.org/10.1155/2015/310645

Ejemplares similares

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009)

Inhibition of (pro)renin Receptor Contributes to Renoprotective Effects of Angiotensin II Type 1 Receptor Blockade in Diabetic Nephropathy
por: Zhang, Lin, et al.
Publicado: (2017)

Renin–angiotensin system blockade for the risk of cancer and death
por: Shen, Jian, et al.
Publicado: (2016)

Single versus dual blockade of the renin-angiotensin system in patients with IgA nephropathy
por: Lennartz, David Paul, et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
por: Lozano-Maneiro, Luz, et al.
Publicado: (2015)

The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection
por: Carvalho, Patricia Ribeiro de, et al.
Publicado: (2021)

Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
por: Bekassy, Zivile, et al.
Publicado: (2021)

Emerging Therapies for Diabetic Nephropathy Patients: Beyond Blockade of the Renin-Angiotensin System
por: Tanios, Bassem Y., et al.
Publicado: (2012)

Dual Blockade of Renin Angiotensin System in Reducing the Early Changes of Diabetic Retinopathy and Nephropathy in a Diabetic Rat Model
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2014)

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
por: Huang, Rong-Shuang, et al.
Publicado: (2016)

A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin–Angiotensin Systems
por: Schmaier, Alvin H.
Publicado: (2016)

You are what you Eat: Dietary Salt Intake and Renin Angiotensin Blockade in Diabetic Nephropathy
por: Charytan, David M., et al.
Publicado: (2012)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
por: Yang, Byeong Yun, et al.
Publicado: (2012)

STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS
por: Manoharan, Sivananthan, et al.
Publicado: (2017)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
por: Feng, Yan-Huan, et al.
Publicado: (2016)

Prominent hyperplasia of renin-producing juxtaglomerular apparatus after chronic and complete blockade of the renin-angiotensin system in adult IgA nephropathy
por: Abe, Michiaki, et al.
Publicado: (2015)

Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
por: Monteillet, Laure, et al.
Publicado: (2021)

Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study
por: Bagchi, Soumita, et al.
Publicado: (2021)

Renoprotective potential of concomittant medications with SGLT2 inhibitors and renin-angiotensin system inhibitors in diabetic nephropathy without albuminuria: a retrospective cohort study
por: Ishibashi, Tatsuya, et al.
Publicado: (2023)

Effects of dual blockade of the renin–angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT–Hypertension)
por: Imai, Enyu, et al.
Publicado: (2013)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

An Interaction of Renin-Angiotensin and Kallikrein-Kinin Systems Contributes to Vascular Hypertrophy in Angiotensin II-Induced Hypertension: In Vivo and In Vitro Studies
por: Ceravolo, Graziela S., et al.
Publicado: (2014)

Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
por: Cooper, Samantha L., et al.
Publicado: (2021)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Left ventricular hypertrophy and renin-angiotensin system blockade
por: Cowan, Brett R., et al.
Publicado: (2009)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

The dual blockade of the renin–angiotensin system in hemodialysis patients requires decreased dialysate sodium concentration
por: Zwiech, Rafał, et al.
Publicado: (2012)

Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy
por: Lu, Chen Chen, et al.
Publicado: (2018)

Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy
por: Oliveira, Lilian Caroline Gonçalves, et al.
Publicado: (2021)

Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade
por: Chen, Jingjing, et al.
Publicado: (2020)

Unilateral ureteric obstruction: Role of renin angiotensin system blockade on renal recovery: An experimental study
por: Sinha, Anand, et al.
Publicado: (2012)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

The kallikrein-kinin system in diabetic nephropathy
por: Tomita, Hirofumi, et al.
Publicado: (2012)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
por: Koitka, Audrey, et al.
Publicado: (2008)

A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients
por: Gouda, Ahmed S., et al.
Publicado: (2021)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
por: Bloch, Michael J.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m38fmjbisurkvr21ri14k1au7c